The global measles, mumps, rubella vaccine market size is evaluated at USD 2.02 billion in 2025 and is forecasted to hit around USD 4.21 billion by 2034, growing at a CAGR of 8.51% from 2025 to 2034. The North America market size accounted for USD 762.60 million in 2024 and is expanding at a CAGR of 8.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Measles, Mumps, Rubella Vaccine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Measles, Mumps, Rubella Vaccine Market Revenue and Volume, by Type
8.1.1 Monovalent
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Trivalent (combined MMR)
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Tetravalent
8.1.3.1. Market Revenue and Volume Forecast
9.1. Measles, Mumps, Rubella Vaccine Market Revenue and Volume, by Targeted Population
9.1.1. Infants and Children (9 to 12 months)
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Adults
9.1.2.1. Market Revenue and Volume Forecast
10.1. Measles, Mumps, Rubella Vaccine Market Revenue and Volume, by Distribution Channel
10.1.1. Hospitals and Healthcare Institutions
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Vaccine Centers and Public Health Clinics
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Pediatric and Private Healthcare Clinics
10.1.3.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type
11.1.2. Market Revenue and Volume Forecast, by Targeted Population
11.1.3. Market Revenue and Volume Forecast, by Distribution Channel
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type
11.1.4.2. Market Revenue and Volume Forecast, by Targeted Population
11.1.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type
11.1.5.2. Market Revenue and Volume Forecast, by Targeted Population
11.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type
11.2.2. Market Revenue and Volume Forecast, by Targeted Population
11.2.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type
11.2.4.2. Market Revenue and Volume Forecast, by Targeted Population
11.2.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type
11.2.5.2. Market Revenue and Volume Forecast, by Targeted Population
11.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type
11.2.6.2. Market Revenue and Volume Forecast, by Targeted Population
11.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type
11.2.7.2. Market Revenue and Volume Forecast, by Targeted Population
11.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type
11.3.2. Market Revenue and Volume Forecast, by Targeted Population
11.3.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type
11.3.4.2. Market Revenue and Volume Forecast, by Targeted Population
11.3.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type
11.3.5.2. Market Revenue and Volume Forecast, by Targeted Population
11.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type
11.3.6.2. Market Revenue and Volume Forecast, by Targeted Population
11.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type
11.3.7.2. Market Revenue and Volume Forecast, by Targeted Population
11.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type
11.4.2. Market Revenue and Volume Forecast, by Targeted Population
11.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type
11.4.4.2. Market Revenue and Volume Forecast, by Targeted Population
11.4.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type
11.4.5.2. Market Revenue and Volume Forecast, by Targeted Population
11.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type
11.4.6.2. Market Revenue and Volume Forecast, by Targeted Population
11.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type
11.4.7.2. Market Revenue and Volume Forecast, by Targeted Population
11.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type
11.5.2. Market Revenue and Volume Forecast, by Targeted Population
11.5.3. Market Revenue and Volume Forecast, by Distribution Channel
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type
11.5.4.2. Market Revenue and Volume Forecast, by Targeted Population
11.5.4.3. Market Revenue and Volume Forecast, by Distribution Channel
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type
11.5.5.2. Market Revenue and Volume Forecast, by Targeted Population
11.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel
12.1. Merck & Co., Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GSK
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Serum Institute of India Pvt. Ltd.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Sanofi
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Shanghai Institute of Biological Products
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Beijing Institute of Biological Products
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Biological E Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sinovac
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Abbott
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Abbott
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample